Doctor profile · Federal record
Dr. Adnan Kiani, M.D
Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Rheumatology Physician · Cedar Rapids, IA
- NPI 1548611841
- Accepts Medicare
- MIPS 75.5 / 100 · 2023
- 24 yrs in practice
- Licensed in 3 states
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 4 locations .
- Primary practice
-
202 10Th St Se
Cedar Rapids, IA 524032414
(443) 722-9807 - Additional location
-
1 University of New Mexico
Albuquerque, NM 871318350 - Additional location
-
921 Seton Dr Ste C&D
Cumberland, MD 215021852
(301) 724-4337
fax (301) 724-3276 - Additional location
-
3111 Gundersen Dr
Onalaska, WI 546508447
(608) 775-8100
Show 1 more location
Credentials & registration
- NPI registered
- June 2016 — 10 yrs on file
- Profile last updated
- June 12, 2025
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State licenses (3)
- Iowa #MD50959 · Wisconsin #68206 · Maryland #D0090890
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548611841. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
54,228
Distinct HCPCS
10
Medicare allowed
$853,734
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3262 |
Injection, tocilizumab, 1 mg | 22,840 | 13 | $6 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 11,900 | 19 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 6,240 | 78 | $23 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 4,120 | 22 | $33 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 3,300 | 13 | $42 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 667 | 327 | $8 | |
80053 |
Blood test, comprehensive group of blood chemicals | 651 | 318 | $10 | |
85652 |
Red blood cell sedimentation rate, to detect inflammation, automated | 651 | 317 | $3 | |
86140 |
Measurement c-reactive protein for detection of infection or inflammation | 645 | 314 | $5 | |
36415 |
Insertion of needle into vein for collection of blood sample | 522 | 315 | $8 |
In context: peer comparison
Among 3 peers in Cedar Rapids Rheumatology Physician, average services per provider: 2,363. This provider delivers 23× the peer median.Open Payments
Industry payments received
All-time total
$55
Transactions
1
Manufacturers
1
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, INC. | 1 | $54.99 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,168
Patients
451
Total drug cost
$625,519
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisone | Generic | 276 | 112 | $3,234 |
| Methotrexate (Methotrexate Sodium) | Brand | 240 | 93 | $8,993 |
| Hydroxychloroquine Sulfate | Generic | 214 | 97 | $15,778 |
| Leflunomide | Generic | 61 | 31 | $3,113 |
| Folic Acid | Generic | 53 | 22 | $192 |
| Humira(Cf) Pen (Adalimumab) | Brand | 50 | 0 | $452,590 |
| Alendronate Sodium | Generic | 44 | 19 | $868 |
| Allopurinol | Generic | 40 | 18 | $576 |
| Meloxicam | Generic | 37 | 15 | $178 |
| Diclofenac Sodium | Generic | 36 | 13 | $1,267 |
Hospital affiliations
Frequently asked questions
What is Dr. Adnan Kiani's medical specialty?
Dr. Adnan Kiani practices Rheumatology Physician in Cedar Rapids, IA.
Where does Dr. Adnan Kiani practice?
Dr. Adnan Kiani practices at 202 10Th St Se, Cedar Rapids, IA 524032414. Office phone: 4437229807.
What is Dr. Adnan Kiani's NPI?
Dr. Adnan Kiani's National Provider Identifier (NPI) is 1548611841, issued by NPPES.
Does Dr. Adnan Kiani accept Medicare assignment?
Yes. Dr. Adnan Kiani accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adnan Kiani commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.